Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
- PMID: 17464296
- DOI: 10.1038/nrd2243
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Abstract
The polyamines spermidine and spermine and their diamine precursor putrescine are naturally occurring, polycationic alkylamines that are essential for eukaryotic cell growth. The requirement for and the metabolism of polyamines are frequently dysregulated in cancer and other hyperproliferative diseases, thus making polyamine function and metabolism attractive targets for therapeutic intervention. Recent advances in our understanding of polyamine function, metabolic regulation, and differences between normal cells and tumour cells with respect to polyamine biology, have reinforced the interest in this target-rich pathway for drug development.
Similar articles
-
Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues.Proc West Pharmacol Soc. 2005;48:24-30. Proc West Pharmacol Soc. 2005. PMID: 16416654 Review.
-
Polyamine transport in parasites: a potential target for new antiparasitic drug development.Comp Biochem Physiol C Toxicol Pharmacol. 2005 Feb;140(2):151-64. doi: 10.1016/j.cca.2005.02.006. Epub 2005 Mar 29. Comp Biochem Physiol C Toxicol Pharmacol. 2005. PMID: 15907761 Review.
-
Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants.Amino Acids. 2012 Feb;42(2-3):411-26. doi: 10.1007/s00726-011-1012-1. Epub 2011 Aug 28. Amino Acids. 2012. PMID: 21874532 Review.
-
F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.Cancer Res. 2008 Dec 1;68(23):9845-53. doi: 10.1158/0008-5472.CAN-08-2748. Cancer Res. 2008. PMID: 19047165
-
Drugs affecting the cell cycle via actions on the polyamine metabolic pathway.Prog Cell Cycle Res. 2003;5:461-8. Prog Cell Cycle Res. 2003. PMID: 14593741 Review.
Cited by
-
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.Front Oncol. 2012 Nov 16;2:162. doi: 10.3389/fonc.2012.00162. eCollection 2012. Front Oncol. 2012. PMID: 23181218 Free PMC article.
-
Polyamine metabolism in fungi with emphasis on phytopathogenic species.J Amino Acids. 2012;2012:837932. doi: 10.1155/2012/837932. Epub 2012 Aug 22. J Amino Acids. 2012. PMID: 22957208 Free PMC article.
-
Hypericin-loaded in modified theranostic liposome nanoplatform: a preliminary in vivo study of targeting and diagnosis.Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug 24. doi: 10.1007/s00210-024-03379-y. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39180673
-
Novel and emerging targeted-based cancer therapy agents and methods.Tumour Biol. 2015 Feb;36(2):543-56. doi: 10.1007/s13277-015-3184-x. Epub 2015 Feb 9. Tumour Biol. 2015. PMID: 25663495 Review.
-
DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening.J Enzyme Inhib Med Chem. 2023 Dec;38(1):309-318. doi: 10.1080/14756366.2022.2150186. J Enzyme Inhib Med Chem. 2023. PMID: 36451618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
